Patient dies in MacroGenics' cancer study, FDA puts trial on hold
Patient dies in MacroGenics' cancer study, FDA puts trial on hold
Patient dies in MacroGenics' cancer study, FDA puts trial on hold
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.